1 |
GM-CSF in busulfan overdosage.Eur J Haematol. 1990 Sep;45(3):183-4. doi: 10.1111/j.1600-0609.1990.tb00452.x.
|
2 |
Short telomeres resulting from heritable mutations in the telomerase reverse transcriptase gene predispose for a variety of malignancies.Ann N Y Acad Sci. 2009 Sep;1176:178-90. doi: 10.1111/j.1749-6632.2009.04565.x.
|
3 |
Impact of germline CTC1 alterations on telomere length in acquired bone marrow failure.Br J Haematol. 2019 Jun;185(5):935-939. doi: 10.1111/bjh.15862. Epub 2019 Mar 19.
|
4 |
Genetic predisposition syndromes: when should they be considered in the work-up of MDS?.Best Pract Res Clin Haematol. 2015 Mar;28(1):55-68. doi: 10.1016/j.beha.2014.11.004. Epub 2014 Nov 12.
|
5 |
Circulating PIG-A mutant T lymphocytes in healthy adults and patients with bone marrow failure syndromes.Exp Hematol. 2001 Dec;29(12):1403-9. doi: 10.1016/s0301-472x(01)00746-9.
|
6 |
DNA methylation in PRDM8 is indicative for dyskeratosis congenita.Oncotarget. 2016 Mar 8;7(10):10765-72. doi: 10.18632/oncotarget.7458.
|
7 |
Identification of differentially expressed genes and pathways in mice exposed to mixed field neutron/photon radiation.BMC Genomics. 2018 Jun 28;19(1):504. doi: 10.1186/s12864-018-4884-6.
|
8 |
Inherited SHQ1 mutations impair interaction with NAP57/dyskerin, a major target in dyskeratosis congenita. Mol Genet Genomic Med. 2017 Nov;5(6):805-808. doi: 10.1002/mgg3.314. Epub 2017 Aug 15.
|
9 |
TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes.Blood. 2008 Nov 1;112(9):3594-600. doi: 10.1182/blood-2008-05-153445. Epub 2008 Jul 30.
|
|
|
|
|
|
|